Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are a clinical-stage company currently focused on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS).

Our mission is powered by our people. Our core values – be audacious, be curious, be authentic, be engaged, and be accountable – creating a culture of caring. Amylyx has assembled an experienced team ready to take action because the communities we serve have no time to wait. If you share our passion and are determined to tackle some of medicine’s toughest problems, we encourage you to read the opportunity below and apply.

The Opportunity

Reporting to the Senior Director, Market Insights, the Associate Director, Market Research & Competitive Intelligence will lead primary market research and competitive intelligence to support commercialization of avexitide in post-bariatric hypoglycemia (PBH). This highly visible, hands-on role will develop and execute an integrated insights plan spanning foundational, strategic, communications, and tracking research, including HCP and patient attitudes, trial, and usage (ATU) studies.

The role will also lead competitive intelligence efforts that provide timely, objective, and actionable perspectives on the PBH disease state, emerging treatment landscape, competitor activity, and market implications. While PBH and avexitide commercialization will be the primary focus, this individual will provide fit-for-purpose market research and competitive intelligence support for New Products Planning (NPP), pipeline assets, and selected business-development needs.

Responsibilities

PBH insights leadership: Serve as the primary market research and competitive intelligence partner for PBH commercialization, translating business questions into an integrated insights plan that informs market development, launch strategy, and execution.
Patient Journey: Partner with Forecasting, Analytics, Marketing, Market Access, Medical Affairs and other stakeholders to integrate research and secondary data to maintain a deep understanding of the Patient Journey.
Integrated Insights: Share key insights with the organization as needed and as a core team member to the Central Insights Team. Oversee updates to the Facts and Insights document so that it provides an accurate view of insights to the organization
Primary market research: Lead end-to-end qualitative and quantitative research with healthcare professionals, patients, caregivers, and other relevant stakeholders, from problem definition and study design through vendor oversight, analysis, synthesis, and action planning.
Tracking and ATU research: Lead HCP and patient ATU and other tracking research, including KPI definition, questionnaire evolution, wave-to-wave comparability, trend interpretation, and integration of findings into commercialization decisions and launch-readiness planning.
Competitive intelligence leadership: Establish and lead the PBH competitive intelligence process, covering competitor pipelines, clinical data, scientific activity, regulatory developments, business and investor activity, partnerships, market-entry signals, and relevant disease-state developments.
Strategic implications: Move beyond news reporting to assess potential impact, identify risks and opportunities, and recommend actions for brand, medical, market access, commercial, and corporate stakeholders.
CI communication and governance: Maintain competitor profiles, landscape assessments, timelines, trackers, SWOTs, source documentation, and recurring updates, with clear escalation criteria for high-impact developments.
NPP and pipeline support: Provide fit-for-purpose primary research and competitive intelligence for NPP and pipeline assets, including opportunity assessments, target product profile input, unmet-needs exploration, indication prioritization, differentiation, and commercial potential.